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A simple and efficient synthesis of the neuroleptic compound Pipothiazine 1 is described, 
involving the reductive cyclation of (2-nitrophenyl)(phenyl)sulfanes 3 for the formation of the 
phenothiazine ring. 
 






Phenothiazines were the first agents successfully used for the treatment of psychosis; at present, 
they are widely known for their clinical use as antipsychotic, antiemetic, antihypertensive, and 
antihistaminic agents, among other therapeutic uses.1 In recent years, phenothiazines proved to 
act as human cholinesterase inhibitors,2 and on many occasions, they have been characterized as 
multidrug resistance (MDR) reversal agents.3 Neuroleptic phenothiazines have been used for 
over fifty years, and several methods for the preparation of these compounds have been reported, 










Some methods for the synthesis of phenothiazines are well known. Phenothiazines with 
substituents in position 2, 3, and 4 can be obtained via [2-[(2-chlorophenyl)thio]phenyl]amine 
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derivatives.3 A commonly used method for the preparation of 2-substituted phenothiazines is the 
reaction of 2-aminobenzenethiol with derivatives of 2-chloro-1-nitrobenzene followed by 
acetylation and Smiles rearrangement.5, 6 
 This paper describes an alternative synthetic route to Pipothiazine 1 by preparing an 
appropriately substituted phenothiazine followed by aminoalkylation at nitrogen (position 10). 
 
 
Results and Discussion 
 
Preparation of the phenothiazine ring 
For the preparation of the phenothiazine ring in 4 we considered (2-nitrophenyl)(phenyl)sulfane 
3 to undergo cyclization via a nitrene intermediate.7,8 
 The reaction of benzenethiol and o-chloronitrobenzene (2a) in tetrahydrofuran in the 
presence of sodium hydride furnished (2-nitrophenyl)(phenyl)sulfane (3a), which upon treatment 
with triethyl phosphite in cumene9 rendered phenothiazine (4a) (Scheme 1). The reductive 
cyclation of (2-nitrophenyl)(phenyl)sulfane (3a) with ethyl triphosphite reduces the number of 
steps and furnishes compound 4a in good yield. Products 3a10 and 4a11 were characterized by 












4ba: R = H
b: R = SO2Cl




 The sulfonation of phenothiazine (4a) with chlorosulfonic acid failed to afford the desired 
10H-phenothiazine-2-sulfonyl chloride (4b), as indicated by 1H NMR spectra of the reaction 
product. According to the literature, the electrophilic aromatic substitution of the phenothiazine 
ring is difficult because of polysubstitution and facile oxidation of the sulfur atom.12  
 This prompted an alternative approach employing an appropriately substituted benzenethiol 
and o-chloronitrobenzene as the starting materials. Sulfonation of benzenethiol with concentrated 
sulfuric acid at room temperature or at 100 °C yielded a mixture of mercaptobenzenesulfonic 
acid regioisomers; the desired para-isomer could not be isolated as a pure product.  
 Chlorosulfonation of o-chloronitrobenzene (2a) was tested under several conditions; the best 
procedure is addition of chlorosulfonic acid to o-chloronitrobenzene (2a) and heating the mixture 
to 130 °C for 30 h. The resulting product was a solid compound exhibiting a 1H NMR spectrum 
in agreement with the structure of 4-chloro-3-nitrobenzene-1-sulfonyl chloride (2b) (Scheme 2). 
When sulfonyl chloride 2b was treated with dimethylamine in ethanol, a solid product was 
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obtained: 4-chloro-N,N-dimethyl-3-nitrobenzenesulfonamide (2c)13 along with a small amount of 
4-(dimethylamino)-N,N-dimethyl-3-nitrobenzenesulfonamide (5) (Scheme 2). Both products 2c 





















Scheme 2  
 
 The nucleophilic displacement of the chlorine atom in 4-chloro-N,N-dimethyl-3-nitro–
benzenesulfonamide (2c) by benzenethiol rendered (2-nitrophenyl)(phenyl)sulfane (3c)14 as a 
solid product (Scheme 1). Thioether 3c has been previously obtained from the same reactants 
under different reaction conditions, but neither yield nor spectroscopic data have been reported.14  
For the formation of the phenothiazine ring, the reductive cyclization of (2-nitrophenyl)-
(phenyl)sulfane (3b) was performed (Scheme 1). Such a procedure involving a nitrene inter-
mediate has been described for the synthesis of substituted phenothiazines,9 but has not been 
applied to the preparation of N,N-dimethyl-10H-phenothiazine-2-sulfonamide (4c). Structure 4c 
was assigned from spectroscopic data. Compound 4c has been synthesized previously15,16 from 
substituted (2-nitrophenyl)(phenyl)sulfanes 3 by different procedures involving more steps.  
 
Attachment of the aminoalkyl chain at the nitrogen atom of the phenothiazine ring 
First, we studied the incorporation of a 3-carbon chain into 2-(piperidin-4-yl)ethanol (6), a 
commercially available compound, to obtain 3-(4-(2-hydroxyethyl)piperidin-1-yl)-3-oxo–
propanoic acid (7) (Scheme 3). This would enable the attachment of the aliphatic substituent at 
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Scheme 3 
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 To this end, piperidine 6 was heated with malonic acid but the reaction did not afford the 
desired amide 7; instead, the N-acetyl derivative 9 was obtained. 
 Since amide 8 could not be prepared by this approach, the amidation of the unsubstituted 
phenothiazine 4a with β-chloropropanoyl chloride was studied. Amide 10a17 was easily obtained 
both by conventional conditions and by microwave irradiation; the latter method increased the 
yield to 95% within a reaction time of 7 minutes. Subsequent substitution of the chlorine atom in 






















a: R = H












 Applying these conditions to phenothiazine 4c, the reaction with β-chloropropanoyl chloride 
at reflux temperature gave compound 10c15 (62%). Subsequent reaction with 2-(piperidin-4-
yl)ethanol (6) converted 10c into 11c; microwave irradiation provided 11c quantitatively within a 
few minutes. 
 As known from the literature12 the reduction of the carbonyl group using lithium aluminum 
hydride is not appropriate for acyl derivatives of phenothiazine. Therefore, product 11c was 
reduced with diborane in tetrahydrofuran to form Pipothiazine 1 (60%). The spectroscopic data 





We have developed a simple method for the synthesis of the neuroleptic compound Pipothiazine, 
starting from commercially available reagents. 
 
 
Experimental Section  
 
General Procedures. The commercial reagents were used without purification. Melting points 
were determined with a Thomas-Hoover apparatus. Reaction progress was monitored by TLC 
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(aluminum sheets coated with Merck silica gel GF254). Silica gel was used for flash and column 
chromatography (Merck silica gel 60, 230–400 mesh) and for preparative TLC (Merck silica gel 
60 GF254). Microwave irradiation was performed with a domestic oven (150 W). IR spectra were 
recorded using a Perkin-Elmer Spectrum One FT-IR spectrophotometer. NMR spectra were 
recorded on Bruker Avance II 500, Bruker Avance II 400 or Bruker AC 300 spectrometers. Mass 
spectra (MALDI/DCTB, APCI, ESI) were recorded on a Shimadzu QP 5000 spectrometer. 
Microanalyses were performed by Universidad Nacional de la Plata (La Plata-Argentina) on a 
Carlo Erba elemental analyzer 1106. 
 
4-Chloro-3-nitrobenzensulfonyl chloride (2b). Chlorosulfonic acid (12.7 mL, 191.30 mmol) 
was added dropwise to 4-chloro-3-nitrobenzene (2a; 10 g, 63.50 mmol), and the mixture was 
stirred and heated at 130 °C for 30 h. The reaction mixture was poured on ice, the resulting off-
white solid was filtered off and purified by column chromatography (dichloromethane/hexane, 
1:1) to give 2b (9.7 g, 60%); mp 57–60 °C. Rf = 0.56 (dichloromethane/ hexane, 1:1). IR (KBr): 
˜ ν  1546, 1388, 1364, 1182, 1049, 901, 830, 775 cm-1. 1H NMR (500 MHz, CDCl3): δ 7.87 (d, 3J 
= 8.5 Hz, 1H, H-5), 8.18 (dd, 3J = 8.2 Hz, 4J = 1.8 Hz, 1H, H-6), 8.55 (d, 4J = 2.2 Hz, 1H, H-2). 
13C NMR (125 MHz, CDCl3): δ 124.3, 130.5 (2C), 133.7, 134.6, 143.1. MS (MALDI/DCTB): 
m/z (%) 219.9 (100) [M–Cl]+. 
4-Chloro-N,N-dimethyl-3-nitrobenzenesulfonamide (2c)13 and 4-dimethylamino-N,N-
dimethyl-3-nitrobenzenesulfonamide (5). A 33% solution of N,N-dimethylamine in absolute 
ethanol (1.6 mL, 11.70 mmol) was added dropwise to a solution of 4-chloro-3-nitrobenzene-
sulfonyl chloride (2b) (3.00 g, 11.70 mmol) in dichloromethane (5 mL) at –30 °C, followed by 
addition of 50% aq. sodium hydroxide (0.5 mL). The reaction mixture was stirred at –30 °C for 3 
h, then at 25 °C for 2 h. The solvent was evaporated, the residual solid was suspended in water (1 
mL) and extracted with dichloromethane. The organic solvent was removed under reduced 
pressure and the crude solid was purified by flash chromatography (hexane/dichloromethane, 0 
to 100%). The first fractions contained 4-chloro-N,N-dimethyl-3-nitrobenzenesulfonamide (2c) 
as a light yellow crystalline solid (1.86 g, 60%) followed by fractions containing 4-dimethyl-
amino-N,N-dimethyl-3-nitrobenzenesulfonamide (5) as a yellow crystalline solid (308 mg, 20%). 
2c: mp 98–100 °C. Rf = 0.40 (dichloromethane/hexane, 2:1). IR (KBr): ˜ ν  1531, 1360, 1340, 
1154, 1047, 960, 777, 711 cm-1. 1H NMR (300 MHz, CDCl3): δ 2.80 (s, 6H, NMe2), 7.76 (d, 3J= 
8.5 Hz, 1H, H-5) 7.90 (dd, 3J = 8.5 Hz, 4J = 2.3 Hz, 1H, H-6), 8.25 (d, 4J = 2.0 Hz, 1H, H-2). 13C 
NMR (125 MHz, CDCl3): δ 38.0 (2C), 124.9, 131.7, 131.9, 133.2, 136.6, 148.2. MS (ESI) m/z 
(%) 265.0 (25) [M+H]+.  
5: mp 58–59 °C. Rf = 0.20 (dichloromethane/hexane, 2:1). IR (KBr): ˜ ν  1535, 1339, 1235, 1193, 
1043, 887, 669 cm-1. 1H NMR (400 MHz, CDCl3): δ 2.75 [s, 6H, NMe2], 3.05 (s, 6H, NMe2), 7.1 
(d, 3J = 9.0 Hz, 1 H, H-5), 7.75 (dd, 3J = 9.0 Hz, 4J = 2.3 Hz, 1H, H-6), 8.2 (d, 4J = 2.3 Hz, 1H, 
H-2). 13C NMR (100 MHz, CDCl3): δ  37.9 (2C), δ 42.2 (2C), 117.3 (2C), 127.5 (2C), 131.8 
(2C). Anal. calcd. for C10H15N3O4S (273.31): C, 43.95; H, 5.53; N, 15.37; S, 11.73. Found: C, 
43.93; H, 5.57; N, 15.35; S, 11.71.  
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N,N-Dimethyl-3-nitro-4-phenylthiobenzenesulfonamide (3c). A solution of 2c (7 g, 26.47 
mmol) and benzenethiol (3 mL, 29.20 mmol) in freshly distilled THF (32 mL) was added 
dropwise to a suspension of NaH (2 g, 83.30 mmol) in freshly distilled THF (25 mL). After the 
reaction mixture has been stirred at room temperature for 20 h, it was slowly poured on ice. The 
resulting crude product was purified by column chromatography (dichloromethane/hexane, 3:1) 
to afford a yellow solid 3c (8.4 g, 94%); mp 123–125 °C. Rf = 0.50 (dichloromethane/hexane 
3:1). IR (KBr): ˜ ν  1506, 1343, 1330, 1161, 955, 776, 712 cm–1. 1H NMR (500 MHz, CDCl3): δ  
2.75 (s, 6H, NMe2), 7.00 (d, 3J = 8.5 Hz, 1H, H-5), 7.58–7.63 (m, 5H, H-2’, 3´, 4´, 5´, 6´), 7.68 
(dd, 3J = 8.7 Hz, 4J = 2.1 Hz, 1H, H-6), 8.63 (d, 4J = 1.9 Hz, 1H, H-2). 13C NMR (125 MHz, 
CDCl3): δ  37.7 (2C), 125.0, 128.6, 129.2, 130.4 (2C), 130.7, 131.1, 132.8, 135.9 (2C), 144.0, 
145.5. MS (APCI/MeOH): m/z (%) 339.1 (100) [M+H]+.  
N,N-Dimethyl-10H-phenothiazine-2-sulfonamide (4c). A solution of 3c (1.88 g, 5.56 mmol), 
peroxide-free cumene (54 mL) and triethylphosphite (3.7 mL, 21.58 mmol) was refluxed under 
nitrogen for 10 h to give 4c as a yellow solid (1.12 g, 66%). This product was immediately used 
without purification for the next step. An analytical sample of 4c was purified by column 
chromatography (hexane/dichloromethane, 0 to 100%); mp 154–157 ºC. Rf = 0.30 (dichloro-
methane/hexane 3:1). IR (KBr): ˜ ν  3345, 1458, 1332, 1159, 960, 758 cm–1. 1H NMR (500 MHz, 
CDCl3): δ  2.75 (s, 6H, NMe2), 6.40 (s, NH, 1H), 6.60 (d, 3J = 8.0 Hz, 1H, H-8), 6.85 (t, 3J = 8.0 
Hz, 1H, H-6), 6.95 (d, 3J = 8.0 Hz, 1H, H-5), 7.05 (m, 3H, H-1, H-3, H- 7), 7.15 (d, 3J = 8.0 Hz 
,1H, H-4). 13C NMR (100 MHz, CDCl3): δ  38.0 (2C), 112.7, 115.0, 116.6, 121.2, 123.2, 125.0, 
126.7, 126.9, 128.0, 133.8, 140.6, 142.5. MS (APCI/MeOH): m/z (%) 307.0 (100) [M+H]+. 
N-Acetyl-2-(piperidin-4-yl)ethanol (9). A mixture of malonic acid (0.26 g, 2.49 mmol), 2-
(piperidin-4-yl)ethanol (6; 0.22 mL, 1.62 mmol) and anhydrous Na2SO4 was heated to 110 °C for 
6 h. Thereafter, the mixture was cooled, washed with water and extracted with ethyl acetate 
(3x10 mL). The solvent was removed under reduced pressure and the residual oil was purified by 
preparative TLC (dichloromethane/methanol, 4:1). Compound 9 was obtained as oil (163 mg, 
40%). Rf = 0.20 (dichloromethane/methanol, 4:1). IR (film): ˜ ν  3400, 2927, 1734, 1620, 1451, 
1272 cm–1. 1H NMR (400 MHz, CDCl3): δ 1.10–1.20 (m, 2H, CHH), 1.50–1.60 (q, 2H, 3J = 8 
Hz, CH2), 1.70–1.85 (m, 3H), 2.00 (bs, 1H, OH), 2.10 (s, 3H, CH3), 2.50–2.60 (td, 2J = 8.0 Hz, 
3J = 8.0 Hz, 3J = 2.0 Hz, 1H, CHH), 3.00–3.10 (td, 2J = 8.0 Hz, 3J = 8.0 Hz, 3J = 2.0 Hz, 1H, 
CHH), 3.70–3.75 (t, 3J = 8.0 Hz, 2H, CH2OH), 3.75–3.85 (m, 1H, CHH), 4.55–4.65 (m, 1H, 
CHH). 13C NMR (100 MHz, CDCl3): δ 21.5, 31.8, 32.5, 32.6, 39.1, 41.8, 46.7, 60.2, 168.9. Anal. 
calcd. for C9H17NO2 (171.07): C, 63.13; H, 10.01; N, 8.18. Found: C, 63.10; H: 10.02; N, 8.20.  
10-(3-Chloropropionyl)-10H-phenothiazine (10a). 3-Chloropropionyl chloride (2.64 mL, 
27.60 mmol) was added to a stirred solution of 4a (2.22 g, 11.50 mmol) in dry benzene (16 mL) 
under a nitrogen atmosphere. The solution was heated to 130 ºC for 6 h. The solvent was 
removed under reduced pressure and the residue was suspended in dichloromethane, washed 
with NaOH (10%), dried over anhydrous MgSO4, and then the solvent was removed under 
reduced pressure. The crude grey solid was recrystallized to afford a white solid 10a (1.99 g, 
62%); mp 127–130 °C (dichloromethane). Rf = 0.5 (dichloromethane/hexane, 4:1). IR (KBr,): ˜ ν  
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1677, 1589, 1461, 1369, 1257 cm–1. 1H NMR (300 MHz, CDCl3): δ 2.80 (bs, 2H, CH2CO), 3.80 
(m, 2H, CH2Cl), 7.25–7.30 (t, 3J = 7.7 Hz, 2H, H-3, H-7), 7.35–7.40 (t, 3J = 7.4 Hz, 2H, H-2, H-
8), 7.45–7.50 (d, 3J = 7.7 Hz, 2H, Ar), 7.55–7.50 (bs, 2H, Ar). 13C NMR (100 MHz, CDCl3): δ 
37.3, 39.6, 126.7, 126.8, 127.1 (3C), 127.2, 127.8, 128.1, 128.4 (2C), 129.5, 138.2, 168.8.  
A mixture of 3-chloropropionyl chloride (2.64 mL, 27.60 mmol) and 4a (2.22 g, 11.50 mmol) 
was irradiated in a microwave oven at 700 W for 7 min to yield 10a (3.05 g, 95%). 
10-[3-[4-(2-Hydroxyethyl)piperidin-1-yl]propionyl]-10H-phenotiazine (11a). Anhydrous 
K2CO3 (552 mg, 3.78 mmol) and 2-(piperidin-4-yl)ethanol (6; 129 mg, 1.00 mmol) were added 
to a solution of 10a (0.394 g, 0.99 mmol) in dry and freshly distilled DMF (6 mL). The resulting 
mixture was refluxed for 2 h. The solvent was evaporated and the residual dark green oil was 
purified by preparative TLC (dichloromethane/hexane 1:9) to yield 11a as a green oil (189 mg, 
50%). Rf = 0.25 (dichloromethane/hexane, 1:9). IR (film): ˜ ν  3330, 2925, 1671, 1464, 1307 cm–1. 
1H NMR (300 MHz, CDCl3): δ 1.05 (m, 2H, CHH), 1.30 (m, 3H, -CH2CH), 1.50 (d, 3J = 8.0 Hz, 
2H, CH2), 1.70 (m, 2H, CH2), 1.95 (m, 2H, CH2), 2.45 (m, 2H, CH2), 2.55 (m, 4H, 2 CH2), 2.70 
(bs, 1H, OH), 3.45 (t, 3J = 6.3 Hz, 2H, CH2OH), 6.55 (d, 3J = 7.2 Hz, 1H, Ar), 6.83 (t, 3J = 7.5 
Hz, 1H, Ar), 7.00 (d, 3J = 6.9 Hz,1H, Ar), 7.20 (t, 3J = 7.7 Hz 1H, Ar), 7.30 (t, 3J = 6.9 Hz, 2H, 
Ar), 7.45 (d, 3J = 7.7 Hz, 1H, Ar), 7.55 (d, 3J = 7.7 Hz, 1H, Ar). 13C NMR (75 MHz, CDCl3): δ 
30.0, 32.1, 39.5, 53.1, 54.0, 55.2, 58.5, 60.1, 61, 114.2 (2C), 118.8, 123.3 (2C), 127.0, 128.1 
(2C), 128.8 (2C), 139.1, 142.0, 171.2. Anal. calcd. for C22H26N2O2S (382.26): C, 69.08; H, 6.85; 
N, 7.32; S, 8.38. Found: C, 69.10; H, 6.89; N, 7.30; S, 8.35. 
10-(3-Chloropropionyl)-N,N-dimethyl-10H-phenothiazine-2-sulfonamide (10c). As for 10a, 
the reaction of 3-chloropropionyl chloride (2.64 mL, 27.60 mmol) and 4c (2.22 g, 7.25 mmol) in 
dry benzene (16 mL) gave a crude yellowish-white solid that was purified by recrystallization to 
afford a white solid 10c (1.78 g, 62%); mp 195–198 °C (dichloromethane). Rf = 0.25 
(dichloromethane/hexane, 3:1). IR (KBr): ˜ ν  1681, 1334, 1158, 780, 715, 610 cm–1. 1H NMR 
(500 MHz, CDCl3): δ 2.75 (s, 6H, NMe2), 2.80 (bs, 1H, CHHCO), 3.10 (bs, 1H, CHHCO), 3.85 
(m, 2H, CH2Cl), 7.29 (td, 3J = 7.8 Hz, 4J =1.4 Hz, 1H, H-6), 7.37 (td, 3J = 7.6 Hz, 4J =1.4 Hz, 
1H, H-7), 7.50 (m, 2H, H-5, H-8), 7.55 (d, 3J = 8.0 Hz, 1H, H-4), 7.61 (dd, 3J = 8.2 Hz, 4J =1.8 
Hz, 1H, H-3), 7.98 (s, 1H, H-1). 13C NMR (125 MHz, CDCl3): δ  37.4 (2C), 38.2, 39.5, 126.1 
(2C), 127.2, 128.0 (2C), 128.1 (2C), 128.2, 128.7 (2C), 137.6, 138.6, 168.9. MS (APCI/ MeOH): 
m/z (%) 397.1 (50) [M+H)]+. 
A mixture of 3-chloropropionyl chloride (2.64 mL, 27.6 mmol) and 4c (2.22 g, 7.25 mmol) upon 
irradiation in a microwave oven at 700 W for 7 min gave 10c (2.81 g, 98%). 
10-[3-[4-(2-Hydroxyethyl)-piperidin-1-yl]propionyl]-N,N-dimethyl-10H-phenotiazine-2-
sulfonamide (11c). Anhydrous K2CO3 (552 mg, 3.78 mmol) and 2-(piperidin-4-yl)ethanol (6; 
129 mg, 1.00 mmol) were added to a solution of 10c (0.382 g, 1.00 mmol) in dry and freshly 
distilled DMF (6 mL). The resulting mixture was irradiated in a domestic microwave oven at 
150W for 2 min. The solvent was removed under reduced pressure, and the oily residue was 
purified by preparative TLC (dichloromethane/hexane/ethanol, 10:1:0.2). Compound 11c was 
obtained as oil (0.396 g, 81%). Rf = 0.2 (dichloromethane/hexane/ethanol, 10:1:0.2). IR (film): ˜ ν  
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1681, 1334, 1158, 780, 715, 610 cm–1. 1H NMR (500 MHz, CDCl3): δ 1.20-1.50 (m, 6H), 1.60 
(m, 2H), 2.0 (m, 2H), 2.50 (bs, 1H, OH ), 2.62 (m, 2H), 2.75 (s, 6H, NMe2), 2.80 (s, 1H), 3.10 
(bs, 2H), 3.80 (t, 3J = 7.0, 2H, CH2OH), 7.29 (t, 3J = 7.8 Hz, 4J =1.4 Hz, 1H, H-6), 7.37 (td, 3J = 
7.6 Hz, 4J =1.4 Hz, 1H, H-7), 7.50 (m, 2H, H-5, H-8), 7.55 (d, 3J = 8.0 Hz, 1H, H-4), 7.61 (dd, 3J 
= 8.2 Hz, 4J =1.8 Hz, 1H, H-3), 8.00 (s, 1H, H-1). 13C NMR (125 MHz, CDCl3): δ 29.7, 32.1, 
32.8, 37.9 (2C), 39.3, 46.1, 47.2, 54.0, 59.8, 60.25, 122.7, 123.3, 125.9, 127.9, 128.1, 128.4, 
129.8, 131.4, 134.2, 136.0, 137.1, 138.6. MS (APCI/MeOH): m/z (%) 490.2 (100) [M+H]+. Anal. 
calcd. for C24H31N3O4S2  (489.32): C, 58.87; H, 6.38; N, 8.58; S, 13.10. Found: C, 58.85; H, 
6.39; N, 6.40; S, 13.00.  
10-[3-[4-(2-Hydroxyethyl)piperidin-1-yl]propyl]-N,N-dimethyl-10H-phenothiazine-2-
sulfonamide (Pipothiazine, 1). Trifluoroborane etherate (1 mL, 0.79 mmol) was added 
dropwise to a stirred mixture of NaBH4 (294 mg, 7.77 mmol) in diglyme (15 mL) at room 
temperature. The borane gas generated was carried over with nitrogen and bubbled into a 
solution of 11c (81 mg, 0.16 mmol) in dry THF (2 mL). The mixture was stirred at room 
temperature for 48 h. Excess of borane was eliminated by careful addition of diluted HCl until 
pH = 6 was reached. The organic phase was washed with water and the solvent was removed. 
The crude product was purified by preparative TLC (dichloromethane/methanol, 6:1) to afford a 
yellow oil 1 (57 mg, 72%) that was compared with an authentic sample (NMR, IR). Rf = 0.4 
(dichloromethane/ethanol, 8:1). IR (film): ˜ ν  3369, 2917, 2849, 1455, 1408, 1342, 1162, 731, 621 
cm–1. 1H NMR (500 MHz, CDCl3): δ 1.30 (m, 3H), 1.51 (m, 2H), 1.68 (m, 2H), 2.0 (m, 4H), 
2.45 (t, 3J = 7.2 Hz, 2H, NCH2), 2.70 (s, 6H, NMe2), 2.90 (m, 2H), 3.68 (t, J = 6.5 Hz, 2H, 
NCH2), 3.95 (t, J = 6.9 Hz, 2H, CH2OH), 6.95 (m, 2H, Ar), 7.11 (dd, 3J = 7.7 Hz, 4J = 1.5 Hz, 
1H, Ar), 7.14–7.30 (m, 4H, Ar). 13C NMR (125 MHz, CDCl3): δ  24.1, 29.6, 32.0, 32.1, 37.9 
(2C), 39.2, 45.5, 53.8 (2C), 55.6, 60.3, 113.9, 116.1, 121.2, 123.2, 123.5, 127.3, 127.4, 127.7, 
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